Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Futura MedicalAllergy TherapeuticsVita Life SciencesPharmaxisPatrys
SymbolLON:FUMLON:AGYASX:VLSASX:PXSASX:PAB
Price Information
Current PriceGBX 45.75GBX 11.75A$0.72A$0.23A$0.02
52 Week RangeBuyBuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price TargetGBX 60GBX 37.50N/AN/AN/A
% Upside from Price Target31.15% upside219.15% upsideN/AN/AN/A
Trade Information
Market Cap£93.63 million£74.75 million$39.55 million$90.69 million$25.74 million
BetaN/AN/AN/AN/AN/A
Average Volume415,619167,682N/A328,880N/A
Sales & Book Value
Annual Revenue£170.00£72.82 million$41.15 million$6.60 million$514,365.00
Price / Sales550,776.181.030.9613.7550.05
CashflowGBX 4.45 per shareGBX 4.90 per shareA$0.21 per shareA$0.09 per shareA$0.01 per share
Price / Cash10.282.403.392.642.88
Book ValueGBX 4.30 per shareGBX 7 per shareA$0.41 per shareA$0.04 per shareA$0.01 per share
Price / Book0.110.021.755.753.00
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (4.50)GBX (0.50)A$0.04A($0.07)A$0.00
Trailing P/E RatioN/AN/A16.25N/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AA$0.04N/AN/A
Dividend YieldN/AN/A5.59%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A90.91%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A6.20%9.26%47.11%N/A
Current Ratio5.35%3.74%2.18%12.35%15.80%
Quick Ratio5.31%3.08%1.58%11.65%15.80%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees15500N/A64N/A
Shares Outstanding204.66 million636.17 million55.31 million394.32 million1.07 billion
Next Earnings DateN/A9/25/2019 (Estimated)N/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Futura MedicalAllergy TherapeuticsVita Life SciencesPharmaxisPatrys

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel